Two national datasets explored the relationship between pain and cigarette, e-cigarette, cannabis, and alcohol use in cancer survivors.

Melanoma in adolescents and young adults (AYAs) has distinct epidemiologic characteristics, with a declining incidence over the past 2 decades but an increasing trend in all-cause and cancer-specific ...

At the Tandem Meetings 2025, researchers presented a study of scalp cooling in patients undergoing chemotherapy and ASCT.

In a case report published in the World Journal of Oncology, an elderly female patient was diagnosed with mast cell leukemia (MCL), with imaging showing extensive osteoblastic metastatic lesions. MCL ...

Updated results from the NIAGARA trial further support perioperative durvalumab and neoadjuvant chemotherapy as a potential new treatment for patients with muscle-invasive bladder cancer, according to ...

This systematic review sought the effects of communication interventions that combine patient- and clinical-targeted interventions on patient-clinician discussions and patient outcomes.

While this pembrolizumab-based regimen is promising and much needed in this patient population, one should remain cognizant of its high costs and the subsequent impact this may have on patients and ...

A multivariate analysis confirmed the independent prognostic significance of both landmark and longitudinal MRD.

Increased mixed chimerism, as detected by AlloHeme, could predict post-transplant relapse “with a high degree of accuracy,” said Monzr M. Al Malki, MD.

The approval was based on a comprehensive clinical data package, which included a single phase 1 trial and a phase 3 trial.

HealthDay News — Telemedicine adoption is associated with modestly lower use of low-value, point-of-care testing among Medicare beneficiaries, according to a study published online Feb. 24 in JAMA ...

Results of a pilot study showed a support program for caregivers and patients coping with surgery for early-stage lung cancer was feasible and accepted, but other outcomes were inconclusive.